Teladoc Health (NYSE:TDOC) Shares Gap Up – Time to Buy?

Teladoc Health, Inc. (NYSE:TDOC)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $6.59, but opened at $6.97. Teladoc Health shares last traded at $6.9880, with a volume of 870,828 shares traded.

Analyst Ratings Changes

Several research analysts have recently weighed in on TDOC shares. TD Cowen dropped their target price on shares of Teladoc Health from $8.00 to $6.00 and set a “hold” rating on the stock in a research report on Thursday, February 26th. Leerink Partners decreased their price target on shares of Teladoc Health from $8.50 to $5.50 and set a “market perform” rating for the company in a report on Thursday, February 26th. Wells Fargo & Company decreased their price target on shares of Teladoc Health from $8.00 to $6.00 and set an “equal weight” rating for the company in a report on Thursday, February 26th. Weiss Ratings upgraded shares of Teladoc Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Friday, May 22nd. Finally, BMO Capital Markets decreased their price target on shares of Teladoc Health from $8.00 to $5.00 and set a “market perform” rating for the company in a report on Thursday, February 26th. Five research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Teladoc Health has an average rating of “Hold” and a consensus target price of $7.43.

Teladoc Health Trading Up 6.3%

The company has a debt-to-equity ratio of 0.75, a current ratio of 2.80 and a quick ratio of 2.72. The company has a fifty day moving average of $5.92 and a 200-day moving average of $6.21. The firm has a market capitalization of $1.26 billion, a PE ratio of -7.23 and a beta of 2.08.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.01). The firm had revenue of $613.85 million for the quarter, compared to analysts’ expectations of $611.04 million. Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.Teladoc Health’s revenue was down 2.5% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.53) earnings per share. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, sell-side analysts anticipate that Teladoc Health, Inc. will post -0.91 earnings per share for the current fiscal year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, CEO Charles Divita III sold 27,731 shares of Teladoc Health stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $5.49, for a total value of $152,243.19. Following the completion of the sale, the chief executive officer directly owned 364,784 shares in the company, valued at $2,002,664.16. The trade was a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is owned by company insiders.

Institutional Trading of Teladoc Health

A number of institutional investors have recently added to or reduced their stakes in TDOC. Jupiter Asset Management Ltd. lifted its stake in Teladoc Health by 293.9% in the fourth quarter. Jupiter Asset Management Ltd. now owns 3,860,076 shares of the health services provider’s stock valued at $27,021,000 after acquiring an additional 2,880,008 shares during the last quarter. Quantinno Capital Management LP lifted its stake in Teladoc Health by 128.0% in the first quarter. Quantinno Capital Management LP now owns 2,621,378 shares of the health services provider’s stock valued at $14,287,000 after acquiring an additional 1,471,631 shares during the last quarter. Pale Fire Capital SE lifted its stake in Teladoc Health by 74.8% in the first quarter. Pale Fire Capital SE now owns 3,398,491 shares of the health services provider’s stock valued at $18,522,000 after acquiring an additional 1,454,288 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in Teladoc Health by 23.8% in the third quarter. Dimensional Fund Advisors LP now owns 6,889,194 shares of the health services provider’s stock valued at $53,260,000 after acquiring an additional 1,325,106 shares during the last quarter. Finally, Trexquant Investment LP acquired a new stake in Teladoc Health in the fourth quarter valued at approximately $9,156,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.